StockDriftsStockDriftsTop 26 Jones Hill Capital LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | 15.36% | 1.27M | $71.7M | new | $57.96(+1.78%) | 2026-03-31 | |
| VRTX | VERTEX PHARMACEUTICALS INC | 10.4% | 108.6K | $48.5M | new | $449.95(+17.36%) | 2026-03-31 | |
| PCVX | VAXCYTE INC | 8.03% | 644.8K | $37.5M | new | $52.13(+12.02%) | 2026-03-31 | |
| NUVL | NUVALENT INC | 6.61% | 300.8K | $30.8M | new | $101.52(+21.88%) | 2026-03-31 | |
| CAPR | CAPRICOR THERAPEUTICS INC | 5.93% | 909.2K | $27.6M | new | $29.63(-21.67%) | 2026-03-31 | |
| TERN | TERNS PHARMACEUTICALS INC | 5.89% | 521.2K | $27.5M | new | $46.56(+13.72%) | 2026-03-31 | |
| BCAX | BICARA THERAPEUTICS INC | 5.37% | 1.26M | $25.1M | new | $18.36(+57.95%) | 2026-03-31 | |
| ANIP | ANI PHARMACEUTICALS INC | 5.25% | 318.6K | $24.5M | new | $77.92(+10.41%) | 2026-03-31 | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 5.23% | 1.17M | $24.4M | new | $21.98(+52.31%) | 2026-03-31 | |
| ELVN | ENLIVEN THERAPEUTICS INC | 4.98% | 593.0K | $23.2M | new | $27.30(+82.49%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | — | — |
| Top 20 Holdings Unweighted | — | — |
Sign up free to track Jones Hill Capital LP, compare funds side by side, and get alerts the moment positions change.